PO.CL01.06 · 临床研究
Biomarkers Predictive of Therapeutic Benefit 6
-
7710 · PDF 细胞外囊泡免疫肽组学从癌症患者血浆中回收具有免疫原性的新抗原肽 Extracellular vesicle immunopeptidomics recovers immunogenic neoantigen peptides from cancer patient plasma Todd Hembrough, Alan Mark Ezrin, Zackary Opheim, Cheryl Bandoski, Sarah Bennett, Kate Fagan-Solis, Benjamin G. Vincent, William Hoos
-
7712 · PDF Wnt驱动的染色体不稳定性作为PORCN抑制的生物标志物 Wnt-driven chromosomal instability as a biomarker for PORCN inhibition Diego García-López, Azedine Zoufir, Hector De Galard Terraube, Laura Madrid, Amy Cullen, Ania Piskorz, Nicola Wallis, Ruth Plummer, Steven Jackson, Jackie Walling, James D. Brenton, Florian M. Markowetz, Jason Yip, Jose Teles, Geoff Macintyre
- 7713 7713 生物标志物指导的晚期膀胱癌治疗策略 Biomarker-guided treatment approach For advanced bladder cancer Dhasarathan Ganesan, Karina Aguilar, Tianyu yang, Bal L. Lokeshwar, Vinata B. Lokeshwar
-
7714 · PDF 细胞外囊泡糖基化谱预测并影响靶向CLDN18.2的CAR-T细胞疗法对胃肠道癌的治疗结局 Extracellular vesicle glycosylation profilepredictsand affectstherapeutic outcomes ofCLDN18.2-targeted CAR-T cell therapyagainst gastrointestinal cancers Wenran Li, Min Tao, Changsong Qi, Lin Shen, Cheng Zhang
-
7715 · PDF 基线DKK1血浆水平升高是sirexatamab治疗的结直肠癌患者的生物标志物 Elevated baseline DKK1 plasma is a biomarker for sirexatamab treated colorectal cancer patients Zongzhong Tong, Scott Patton, Patty Ormonde-Hanson, Calvin Jia, Cyndi Sirard, Jay Baum, Mike Kagey
-
7716 · PDF 胰腺导管腺癌中肿瘤内在性MHC-II激活增强免疫应答和治疗疗效 Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy Canping Chen, Kyle P. Gribbin, Xi Li, Tugba Ozmen, Furkan Ozmen, Shamilene Sivagnanam, James Kim, Katie E. Blise, Xinxing Yang, Yi Zhang, Dove Keith, Mara H. Sherman, Mushui Dai, Lisa M. Coussens, Charles D. Lopez, Rosalie C. Sears, Gordon B. Mills, Katelyn T. Byrne, Zheng Xia
-
7717 · PDF TRPM4表达预测前列腺癌对Acetalax的敏感性 TRPM4 expression predicts Acetalax sensitivity in prostate cancer Yuka Hoshi, William C. Reinhold, Daiki Taniyama, Yoshitaka Inoue, Augustin Luna, Suresh Kumar, NAI-YUN SUN, Yoo Sun Kim, Yin Juanjuan, Nitin Roper, Adam G. Sowalsky, Naoko Takebe, Yves Pommier
-
7718 · PDF 硬脂酸-巨噬细胞串扰将MIF-CD44信号鉴定为肺癌起始中的治疗靶点 Stearic acid-macrophage crosstalk identifies MIF-CD44 signaling as a therapeutic target in lung cancer initiation Amrita Roy, Greta Forbes, Dikshaya Prabhakara, Tyler Faith, Apurva Mallisetty, Samuel Weinberg, Alicia Hulbert, Frank D. Weinberg
-
7719 · PDF 探索晚期癌症患者对尼达尼布(nintedanib)与贝伐珠单抗(bevacizumab)联合治疗应答的生物标志物预测因子:一项1b期研究的相关性研究 Exploring biomarker predictors of response to nintedanib and bevacizumab combination therapy in advanced cancer patients: Correlative studies from Phase 1b study Ravi Kumar Paluri, Anup Kasi, Francisco Robert, Gagan Deep, Ashish Manne
- 7720 7720 在一个大型中国肺癌队列中DNA与RNA NGS对FGFR2融合检测的差异 Differences in FGFR2 fusion detection between DNA and RNA NGS in a large Chinese lung cancer cohort Wenxue Chen, Xinlin Yu, Lipeng Bai, Can Wen, Wennan Zhang, Wanwan Zou, Zhiliang Liu, Ruijia Sun, Mengli Huang
-
7721 · PDF 复发性头颈部鳞状细胞癌中PD-L1、desmocollin 3与间质淋巴细胞之间的相关性 Correlation between PD-L1, desmocollin 3, and stromal lymphocytes in recurrent head and neck squamous cell carcinomas Vedanti Newaskar, Shivani Sharma, Bakulesh M. Khamar
-
7722 · PDF nelmastobart疗效的生物标志物:结直肠癌中BTN1A1表达与肿瘤微环境动态 Biomarkers of nelmastobart efficacy: BTN1A1 expression and tumor microenvironment dynamics in colorectal cancer Bong-Ki Hong, Soohyeon Lee, Andrew H. Park, Young-Seung Kim, Chunai Wu, Seung-Hoon Lee, Jong-Su Park, Stephen S. Yoo
-
7723 · PDF 为多中心临床试验实施一种新型免疫监测策略,以实现澳大利亚偏远地区个体癌症预后的公平性 Implementation of a novel immune monitoring strategy for multicenter clinical trials to enable equity in cancer prognosis for individuals from remote settings of Australia Natalie J. Smith, Michael Cohen, Lauren J. Tracey, Julie Alipaz, Christina Loh, David A. King, Neha Pulyani, Rebecca Auzins, Elin S. Gray, Sandra Taylor, Rajat Rai, Steven Kao, Barbara Fazekas de St Groth, Helen McGuire
-
7724 · PDF 一种基于循环GPNMB的多模态模型整合肿瘤-免疫串扰以预测食管癌免疫治疗应答 A circulating GPNMB-based multimodal model integrates tumor-immune crosstalk to predict immunotherapy response in esophageal cancer Liang Zhu, Xiaoyuan Wang, Guoyu Cheng, Yancheng Lai, Lan Lan, Zhenghao Dong, Zhixuan You, Xinjie Chen, Ziyi He, Xinyi Xiao, Lingxuan Zhu, Rucheng Liu, Shaosen Zhang, Dongxin Lin, Chen Wu, Jiang Chang
-
7725 · PDF 整合分子分析识别晚期前列腺癌对sacituzumab govitecan应答的预测因子 Integrative molecular profiling identifies predictors of response to sacituzumab govitecan in advanced prostate cancer Jacque Lyman, Todd Knutson, Allison Haaning, Braedan M. McCluskey, Yingming Li, Jamie M. Sperger, Rendong Yang, Christos Kyriakopolous, Susan F. Slovin, Scott T. Tagawa, Joshua M. Lang, Scott M. Dehm
-
7726 · PDF 胃癌中治疗靶点CDH17的表达谱 Expression profile of therapeutic target CDH17 in gastric cancer Fei Chu, Jiaxing Zhao, Dan Huang, Hao Luo, Aaron Hong, Ye Tian, Chang Liu, David Chu, Jim Lu
-
7727 · PDF 整合FHIT和IDH2生物标志物预测急性髓系白血病对DCPS抑制的合成致死反应 Integrated FHIT and IDH2 biomarkers predict synthetic lethal response to DCPS inhibition in acute myeloid leukemia Madhurendra Singh, Francesca Grassi, Lisa Bast, Vladimir Talibov, Camilla Silvander, Simon Moussaud, Matthieu Desroses, Angelo De-Milito, Julian Walfridsson, Andreas Höglund, Martin Andersson
-
7728 · PDF 糖原分支酶1作为结直肠癌CMS4亚型的代谢决定因素和预后驱动因素 Glycogen branching enzyme 1 as a metabolic determinant and prognostic driver of the CMS4 subtype in colorectal cancer Fang-Chi Hsu, Leila Su, Frank Luh, Yi-Fan Chen, Xin Wang, Yun Yen
-
7729 · PDF 磷酸化FRS2(pFRS2)作为福尔马林固定石蜡包埋肿瘤切片中FGFR突变或融合活性评估的生物标志物 Phosphorylated FRS2 (pFRS2) as a biomarker for FGFR mutation or fusion activity assessment in formalin-fixed paraffin-embedded tumor sections Peter Feiszt, Kristopher A. Lofgren, Paraic A. Kenny
- 7730 7730 一种新型超灵敏基于qPCR的液体活检检测:外周血浆来源cfDNA中ESR1突变的检测 A novel ultra-sensitive qPCR-based liquid biopsy assay: ESR1 mutation detection in peripheral plasma derived cfDNA Fei Ma, Haili Qian, Wenna Wang, Yongpan Yan, Bowen Ji, Yuwei Pei
-
7731 · PDF 与可切除胆道癌新辅助度伐利尤单抗联合吉西他滨、顺铂和白蛋白结合型紫杉醇(DURGAP)反应相关的肿瘤免疫微环境特征 Tumor immune microenvironment features associated with response to neoadjuvant durvalumab plus gemcitabine, cisplatin, and nab-paclitaxel (DURGAP) in resectable biliary tract cancer Huiying Yan, Wenxin Li, Linze Xu, Rentao Li, Linlin Fu, Qi Qi, Xihao Zhang, Jihui Hao, Huikai Li, Yang Liu
-
7732 · PDF 与MUC4相关的基质-免疫空间转录组特征识别HER2阳性乳腺癌曲妥珠单抗耐药的潜在生物标志物 A stromal-immune spatial transcriptomic signature associated with MUC4 identifies potential biomarkers of trastuzumab resistance in HER2-positive breast cancer Maria F. Mercogliano, Nadine Schrode, Kristin Beaumont, Roxana Schillaci
-
7733 · PDF 用于癌症研究的可靠抗体:TROP2作为Abcam增强验证框架的案例研究 Reliable antibodies for cancer research: TROP2 as a case study of Abcam's enhanced validation framework Caroline S. Hirst, JK Tanjore Ramanathan, Nadine Nelson, Antonella Galli, Will Howat, Silvia Sbacchi
-
7734 · PDF gap评分:药物敏感性的功能性生物标志物 The gap score: A functional biomarker of drug sensitivity Sharon B. Cantor, Jenna Whalen, Tokio Sano
-
7735 · PDF HER2表达和肿瘤浸润淋巴细胞可预测HER2阳性转移性结直肠癌对tucatinib联合trastuzumab的疗效(MOUNTAINEER):一项多中心Ⅱ期试验的探索性分析 HER2 expression and tumor-infiltrating lymphocytes predict response to tucatinib plus trastuzumab in HER2 -positive metastatic colorectal cancer (MOUNTAINEER): Exploratory analysis of a multicenter, Phase II trial Mitsuho Imai, John H. Strickler, Woochan Hwang, Kara Bonneau, Andrew B. Nixon, Jongchan Park, Chang Ho Ahn, Tanios Bekaii-Saab, Takayuki Yoshino
-
7736 · PDF 非小细胞肺癌中罕见的EGFR顺式复合L833V/H835L突变具有致癌性并且是EGFR酪氨酸激酶抑制剂的治疗靶点 Rare EGFR cis compound L833V/H835L mutation in non-small cell lung cancer is oncogenic and a therapeutic target of EGFR tyrosine kinase inhibitors Yo Han Jeon, Ahjin Lim, Myung Kyung Choi, Hee Seong Choi, Yurimi Lee, Hyunju Song, Hyun-Soo Cho, Jeonghee Cho, Yoon-La Choi
-
7737 · PDF 基线CD16+ NK细胞与晚期肝细胞癌nivolumab联合ipilimumab免疫治疗的临床结局相关 Baseline CD16 + NK cells are associated with clinical outcome of nivolumab plus ipilimumab immunotherapy in advanced hepatocellular carcinoma Hongjae Chon, Narim Lee, Hannah Yang, Junho Kang, Won Suk Lee, So Jung Kong, Beodeul Kang, Jung Sun Kim, Ho Yeong Lim, Jung Kyoon Choi, Chan Kim